Tofacitinib 2% w/w (TOFASIG): Uses, Benefits, Side Effects & International Supply Guide
Website: Meds Connect India
Product name: TOFASIG
Active ingredient: Tofacitinib
Strength: 2% w/w
Dosage form: Topical ointment — confirm the exact formulation on the
product packaging
Therapeutic category: Janus kinase (JAK) inhibitor
Supplier profile: Indian medicine exporter and drop-shipping supplier
with five years of experience
1. Introduction to TOFASIG Tofacitinib 2% w/w
Tofacitinib 2% w/w (TOFASIG) is a topical formulation
containing tofacitinib, a medicine that acts on Janus kinase (JAK) pathways
involved in inflammatory and immune responses.
Topical tofacitinib has been developed for certain
inflammatory skin conditions. In India, a 2% tofacitinib ointment has been
approved for the treatment of mild-to-moderate atopic dermatitis in adults aged
18 years and above, subject to its approved product information. Always verify
the specific brand, manufacturer, and approved indication before use.
At Meds Connect India, we aim to help international
customers and healthcare professionals access product information and request
quotations for pharmaceutical products through our export and drop-shipping
services.
2. Product Composition and Specifications
|
Product detail |
Information |
|
Brand:: |
TOFASIG |
|
Generic name:: |
Tofacitinib |
|
Strength:: |
2% w/w |
|
Formulation:: |
Topical preparation; verify ointment or other form on the
label |
|
Drug class:: |
JAK inhibitor |
|
Primary clinical context |
Atopic dermatitis, where approved |
|
Route of administration:: |
Topical application, according to the product label |
|
| |
|
Storage:: |
Follow the manufacturer's packaging and leaflet |
3. How Does Tofacitinib Work?
Tofacitinib inhibits Janus kinase enzymes, which participate
in signalling pathways used by certain cytokines involved in inflammation and
immune responses.
By modulating these pathways, topical tofacitinib may help
reduce inflammatory skin symptoms associated with the condition for which it
has been prescribed.
It is not a general-purpose moisturiser, cosmetic cream, or
treatment suitable for every skin rash. A dermatologist should determine
whether it is appropriate for an individual patient.
4. Potential Benefits and Advantages
A. Helps manage inflammatory skin symptoms
When prescribed for an appropriate condition, topical
tofacitinib may help reduce inflammation and related symptoms such as itching
and redness.
B. Targeted topical application
A topical formulation is applied directly to the affected
skin rather than taken as a tablet. However, topical administration does not
guarantee zero absorption into the bloodstream or eliminate all
medication-related risks.
C. Non-steroidal treatment option
Tofacitinib is not a corticosteroid. Depending on the
patient's diagnosis and treatment plan, a dermatologist may consider it as a
non-steroidal treatment option.
D. May support improved daily comfort
When treatment is effective, reducing itching and
inflammation may help improve sleep, comfort, and everyday activities for
people living with inflammatory skin conditions.
E. A specialised dermatology product
Its targeted mechanism makes tofacitinib an option that
healthcare professionals may evaluate for selected patients, based on the
approved indication and available clinical evidence.
Clinical note: Individual results vary. These
potential benefits should not be interpreted as a guarantee of effectiveness or
as evidence that TOFASIG is appropriate for every skin condition.
5. Disadvantages, Side Effects and Precautions
Like other medicines that affect immune signalling,
tofacitinib requires careful use and professional supervision.
Possible side effects
Depending on the formulation and individual response,
possible adverse effects may include:
- Burning,
irritation, or discomfort at the application site.
- Redness,
itching, or other local skin reactions.
- Increased
susceptibility to infections, depending on systemic exposure and
individual risk.
- Other
unexpected reactions that require medical assessment.
The exact frequency and risk profile should be checked
against the approved leaflet for the specific TOFASIG product.
Important safety precautions
- Use
only for the condition and duration recommended by a qualified healthcare
professional.
- Do
not apply to infected, broken, or severely irritated skin unless
specifically directed by your doctor.
- Avoid
contact with the eyes, mouth, and other mucous membranes.
- Tell
your doctor about existing infections, recurrent herpes infections,
immune-system disorders, pregnancy, breastfeeding, and other medicines you
use.
- Do
not combine it with other immunosuppressive treatments unless your
prescriber has reviewed the risks.
- Seek
prompt medical advice for signs of a serious infection or a severe
allergic reaction.
Serious-risk clarification: Oral tofacitinib carries
important warnings about serious infections, certain cancers, major
cardiovascular events, blood clots, and mortality in particular patient
populations. These findings must not be directly equated with the risk of
topical 2% ointment, but they underscore why the specific topical formulation
should be used only with appropriate medical guidance.
6. Who Should Use TOFASIG?
TOFASIG should be considered only after a healthcare
professional has confirmed the diagnosis and assessed the product's
suitability.
It may be considered in the clinical context of an approved
inflammatory skin condition, such as mild-to-moderate atopic dermatitis in
eligible adults where the relevant product is authorised.
It should not be self-prescribed for eczema, psoriasis,
vitiligo, hair loss, or other skin disorders merely because these conditions
involve inflammation or immune activity. Approval and evidence differ by
condition, formulation, and country.
7. Directions for Use
- Clean
and gently dry the affected area as instructed by your healthcare
professional.
- Apply
the prescribed amount to the specified area.
- Wash
your hands after application unless the hands are the treatment area.
- Do
not cover the area with an airtight dressing unless instructed.
- Do
not increase the frequency or duration of use without medical advice.
- Contact
your doctor if the condition worsens, an infection develops, or treatment
does not produce the expected improvement.
The amount applied, application frequency, treatment
duration, and maximum area of skin treated must follow the specific product's
approved instructions.
8. Storage and Handling
- Store
the medicine according to the manufacturer's label.
- Protect
it from excessive heat, moisture, and direct sunlight where instructed.
- Keep
the container closed when not in use.
- Keep
out of the reach of children.
- Do
not use expired, damaged, or visibly altered products.
- Retain
the original packaging and batch information for traceability.
9. International Shipping and Drop-Shipping by Meds
Connect India
Meds Connect India is an India-based medicine exporter and
drop-shipping supplier with five years of experience in pharmaceutical supply
enquiries.
We can review enquiries for TOFASIG and other pharmaceutical
products, subject to stock availability, supplier verification,
destination-country rules, and export eligibility.
Shipping process
Step 1 — Product enquiry: Share the requested brand,
strength, quantity, and destination country.
Step 2 — Availability and quotation: Our team can
review availability, packaging details, applicable charges, and the permitted
shipping options.
Step 3 — Documentation and compliance: Orders are
subject to the required export documentation, prescription requirements where
applicable, import permits, and destination-country regulations.
Step 4 — Dispatch confirmation: For accepted orders,
dispatch information and tracking details can be provided when available.
Step 5 — Delivery and follow-up: Delivery timelines
depend on the destination, authorised carrier, customs processing, and local
import procedures.
Shipping charges and delivery timelines
Shipping charges and delivery estimates depend on the
destination, parcel weight and dimensions, courier service, and applicable
customs or handling requirements. A confirmed quotation should be obtained
before placing an order.
We do not guarantee customs clearance, a particular delivery
date, or delivery to a country where the medicine is restricted or
unauthorised.
Countries we deal in
Meds Connect India welcomes enquiries from international
customers. Availability and shipment eligibility must be verified separately
for each destination.
Customers may enquire from markets including:
- United
States
- United
Kingdom
- Australia
- Canada
- European
countries
- Asian
countries
- Other
eligible international destinations
These are enquiry markets, not a guarantee that TOFASIG can
legally be exported to or imported into every listed country. Shipments will be
considered only where the product and transaction comply with applicable laws.
10. Why Choose Meds Connect India?
Five years of business experience
We have five years of experience in medicine export and
drop-shipping enquiries, helping customers coordinate product requirements and
supply arrangements.
Product-focused quotations
Customers can share the exact brand, strength, required
quantity, and destination to request a quotation based on current availability.
International customer support
Our team can assist with product enquiries, shipping
estimates, applicable documentation requirements, and dispatch updates for
accepted orders.
Multiple product enquiries
Customers may enquire about TOFASIG alongside other
pharmaceutical products, subject to availability and the relevant regulatory
requirements.
Emphasis on documentation and compliance
We encourage customers to verify product identity,
manufacturer details, batch information, expiry dates, and applicable
regulatory requirements before purchase.
Our commitment: We aim to provide clear communication
about product availability, pricing, shipping arrangements, and documentation.
We do not promise guaranteed therapeutic outcomes or customs clearance.
11. Frequently Asked Questions (FAQs)
Q1. What is TOFASIG 2% w/w?
TOFASIG is the product name supplied for a tofacitinib 2%
w/w topical preparation. Confirm the exact formulation and manufacturer using
the product label.
Q2. What is tofacitinib 2% w/w used for?
Topical tofacitinib 2% has been approved in India for
certain adult patients with mild-to-moderate atopic dermatitis. The authorised
use of the particular brand must be verified locally.
Q3. Is TOFASIG a steroid?
No. Tofacitinib is a Janus kinase inhibitor, not a
corticosteroid.
Q4. How long does it take to work?
The response varies by patient, diagnosis, and treatment
plan. Your dermatologist can advise when improvement should be assessed and
whether treatment should continue.
Q5. Can TOFASIG be used for hair loss or vitiligo?
Do not assume that it is suitable for these conditions.
Evidence, product formulation, and regulatory approval differ. Use it for these
conditions only if a qualified specialist specifically recommends the
treatment.
Q6. What are the possible side effects?
Local irritation, redness, itching, or burning may occur.
Other risks depend on the formulation and patient. Review the product leaflet
and seek medical advice if concerning symptoms develop.
Q7. How should TOFASIG be stored?
Follow the storage instructions on the original
manufacturer's packaging. Do not use the product after its expiry date.
Q8. Can Meds Connect India supply TOFASIG
internationally?
International enquiries can be reviewed. Supply depends on
stock, product verification, export eligibility, and the destination country's
import regulations.
Q9. How can I request a quotation?
Contact Meds Connect India with the requested product,
strength, quantity, destination country, and postcode. A quotation can be
prepared after availability and shipping eligibility are checked.
Q10. Are shipping charges fixed?
No. Charges depend on destination, shipment dimensions and
weight, carrier, and applicable handling requirements. Request a current
quotation.
Q11. Is delivery guaranteed?
No. Delivery is subject to carrier operations, customs
procedures, regulatory approval, and other circumstances outside the supplier's
control.
12. Conclusion
Tofacitinib 2% w/w is a specialised topical medicine that
works by modulating JAK-mediated inflammatory signalling. It may offer a
treatment option for selected patients when prescribed for an appropriate,
authorised indication. Correct product identification, medical supervision, and
awareness of potential side effects are essential.
Meds Connect India welcomes product and export enquiries
from eligible international markets. Contact our team to request current
availability, product details, and a destination-specific quotation, subject to
applicable laws and shipping eligibility.
Meds Connect India – Reliable Pharmaceutical Export & Drop-Shipping Services from India
